Log in

Homology Medicines SEC Filings & 10K Form (NASDAQ:FIXX)

$13.02
-0.37 (-2.76 %)
(As of 10/21/2019 03:24 AM ET)
Today's Range
$12.66
Now: $13.02
$13.60
50-Day Range
$12.81
MA: $18.09
$21.56
52-Week Range
$12.66
Now: $13.02
$31.80
Volume282,578 shs
Average Volume217,528 shs
Market Capitalization$572.49 million
P/E RatioN/A
Dividend YieldN/A
Beta0.09

SEC Filings

Homology Medicines (NASDAQ:FIXX) SEC Filings

DateFilerForm TypeView
10/02/2019
3:07 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:05 PM
Homology Medicines (Issuer)
Kelly Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:42 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:40 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:39 PM
Homology Medicines (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:01 PM
Homology Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
3:18 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
3:16 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
4:36 PM
Homology Medicines (Issuer)
REICIN ALISE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
4:35 PM
Homology Medicines (Issuer)
REICIN ALISE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/15/2019
4:15 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2019
3:30 PM
Homology Medicines (Issuer)
Rasty Siyamak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:32 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:30 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:45 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
6:33 PM
Homology Medicines (Issuer)
Wheeler Cameron (Reporting)
Form 4/A
06/11/2019
3:47 PM
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Flynn James E (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:11 PM
Gregory Richard J. (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:11 PM
Homology Medicines (Issuer)
Wheeler Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:11 PM
Homology Medicines (Issuer)
Thistle Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:10 PM
Homology Medicines (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:09 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:09 PM
GILLIS STEVEN (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:05 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
5:16 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
5:13 PM
Homology Medicines (Issuer)
Kelly Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
5:11 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
5:10 PM
Homology Medicines (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
5:09 PM
Homology Medicines (Issuer)
Rasty Siyamak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
4:58 PM
ARCH Venture Fund VIII Overage, L.P. (Reporting)
ARCH Venture Fund VIII, L.P. (Reporting)
ARCH Venture Partners VIII, L.P. (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Homology Medicines (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
3:26 PM
5AM Co-Investors IV, L.P. (Reporting)
5AM Partners IV, LLC (Reporting)
5AM Ventures IV, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
Homology Medicines (Issuer)
ROCKLAGE SCOTT M (Reporting)
Schwab Andrew J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
3:24 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2019
3:03 PM
Homology Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
3:57 PM
Homology Medicines (Filer)
Form DEFA14A
04/25/2019
3:54 PM
Homology Medicines (Filer)
Form DEF 14A
04/15/2019
6:38 PM
Deerfield Healthcare Innovations Fund, L.P. (Reporting)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt HIF, L.P. (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Flynn James E (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
3:21 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2019
4:18 PM
Homology Medicines (Filer)
Form 424B5
04/09/2019
11:15 PM
Homology Medicines (Filer)
Form EFFECT
04/08/2019
3:51 PM
Homology Medicines (Filer)
Form 424B5
04/08/2019
3:48 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
4:29 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
3:46 PM
Homology Medicines (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/12/2019
6:01 AM
Homology Medicines (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
2:10 PM
ARCH Venture Fund VIII, L.P. (Filed by)
Homology Medicines (Subject)
Form SC 13G
02/04/2019
3:05 PM
Homology Medicines (Subject)
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Form SC 13G
01/10/2019
2:39 PM
Homology Medicines (Subject)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G
12/18/2018
4:27 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
4:25 PM
Homology Medicines (Issuer)
Kelly Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
4:21 PM
Homology Medicines (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
4:20 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
7:10 PM
5AM Co-Investors IV, L.P. (Reporting)
5AM Partners IV, LLC (Reporting)
5AM Ventures IV, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
Homology Medicines (Issuer)
ROCKLAGE SCOTT M (Reporting)
Schwab Andrew J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
7:10 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
5:09 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
5:08 PM
5AM Co-Investors IV, L.P. (Reporting)
5AM Partners IV, LLC (Reporting)
5AM Ventures IV, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
Homology Medicines (Issuer)
ROCKLAGE SCOTT M (Reporting)
Schwab Andrew J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2018
4:05 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2018
4:05 PM
5AM Co-Investors IV, L.P. (Reporting)
5AM Partners IV, LLC (Reporting)
5AM Ventures IV, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
Homology Medicines (Issuer)
ROCKLAGE SCOTT M (Reporting)
Schwab Andrew J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
3:02 PM
Homology Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/27/2018
7:44 PM
Homology Medicines (Issuer)
Kelly Timothy P (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/13/2018
3:02 PM
Homology Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/16/2018
3:05 PM
Homology Medicines (Issuer)
SHAH MAHENDRA (Reporting)
Form 4/A
05/14/2018
3:02 PM
Homology Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/11/2018
3:06 PM
Homology Medicines (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G
04/06/2018
3:20 PM
Flynn James E (Filed by)
Homology Medicines (Subject)
Form SC 13D
04/04/2018
7:56 PM
Deerfield Healthcare Innovations Fund, L.P. (Reporting)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt HIF, L.P. (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Flynn James E (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2018
6:09 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4/A
04/04/2018
5:41 PM
5AM Co-Investors IV, L.P. (Reporting)
5AM Partners IV, LLC (Reporting)
5AM Ventures IV, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
Homology Medicines (Issuer)
ROCKLAGE SCOTT M (Reporting)
Schwab Andrew J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2018
3:45 PM
Homology Medicines (Issuer)
SHAH MAHENDRA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2018
3:27 PM
GILLIS STEVEN (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2018
12:33 PM
Fullerton Management Pte Ltd (Reporting)
Homology Medicines (Issuer)
Temasek Holdings Ltd (0001021944) (Reporting)
Temasek Life Sciences Private Ltd (Reporting)
TLS Beta Pte. Ltd. (Reporting)
V-Sciences Investments Pte Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2018
3:02 PM
Homology Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2018
12:36 PM
Homology Medicines (Filer)
Form CT ORDER
03/29/2018
6:32 PM
Homology Medicines (Issuer)
Thistle Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
6:31 PM
Homology Medicines (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
6:30 PM
Homology Medicines (Issuer)
Wheeler Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
6:28 PM
Homology Medicines (Issuer)
Seymour Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
6:27 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
6:27 PM
Gregory Richard J. (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
6:27 PM
Homology Medicines (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
6:19 PM
Homology Medicines (Issuer)
Rasty Siyamak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
5:47 PM
Homology Medicines (Issuer)
Smith W Bradford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
5:34 PM
GILLIS STEVEN (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
5:30 PM
Homology Medicines (Issuer)
SHAH MAHENDRA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
4:22 PM
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Flynn James E (Reporting)
Homology Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
4:19 PM
Homology Medicines (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/29/2018
4:02 PM
Homology Medicines (Filer)
Form 424B4
03/28/2018
8:56 PM
Fullerton Management Pte Ltd (Reporting)
Homology Medicines (Issuer)
Temasek Holdings Ltd (0001021944) (Reporting)
Temasek Life Sciences Private Ltd (Reporting)
TLS Beta Pte. Ltd. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
11:15 PM
Homology Medicines (Filer)
Form EFFECT
03/27/2018
7:47 PM
5AM Co-Investors IV, L.P. (Reporting)
5AM Partners IV, LLC (Reporting)
5AM Ventures IV, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
Homology Medicines (Issuer)
ROCKLAGE SCOTT M (Reporting)
Schwab Andrew J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
5:41 PM
Deerfield Healthcare Innovations Fund, L.P. (Reporting)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt HIF, L.P. (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Flynn James E (Reporting)
Homology Medicines (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
5:26 PM
Homology Medicines (Issuer)
Rock Springs Capital LLC (Reporting)
Rock Springs Capital Management LP (Reporting)
Rock Springs Capital Master Fund LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
5:25 PM
Homology Medicines (Issuer)
NOVARTIS AG (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
5:19 PM
Homology Medicines (Issuer)
Vida Ventures, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
5:05 PM
ARCH Venture Fund VIII Overage, L.P. (Reporting)
ARCH Venture Fund VIII, L.P. (Reporting)
ARCH Venture Partners VIII, L.P. (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Homology Medicines (Issuer)
NELSEN ROBERT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
5:02 PM
Chatterjee Saswati (Reporting)
Homology Medicines (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
5:02 PM
Homology Medicines (Issuer)
Wheeler Cameron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
5:01 PM
Homology Medicines (Issuer)
Thistle Mary (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
4:59 PM
Homology Medicines (Issuer)
SHAH MAHENDRA (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
4:58 PM
Homology Medicines (Issuer)
Patterson Matthew R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2018
4:58 PM
Homology Medicines (Issuer)
PARMAR KUSH (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel